Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial

Faster, Cleaner, Better.

Dare Bioscience Inc (DARE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2020	12-2019	12-2018	12-2017	12-2016
Cash Flows From Operating Activities
Net Income	-27,401	-14,264	-16,739	-11,503	-673
Depreciation Amortization	43	11	5,190	7,491	N/A
Accounts payable and accrued liabilities	-62	609	152	218	N/A
Other Working Capital	1,543	706	625	1,140	291
Other Operating Activity	642	-378	504	114	9
Operating Cash Flow	$-25,235	$-13,316	$-10,268	$-2,540	$-372

Cash Flows From Investing Activities
PPE Investments	-18	N/A	-12	N/A	N/A
Net Acquisitions	N/A	6,144	-507	9,918	N/A
Investing Cash Flow	$-18	$6,144	$-519	$9,918	$N/A

Cash Flows From Financing Activities
Change In Short Term Borrowing	N/A	N/A	N/A	155	198
Debt Issued	367	N/A	N/A	N/A	N/A
Common Stock Issued	24,763	5,152	10,112	N/A	N/A
Financing Cash Flow	$25,131	$5,152	$10,112	$155	$198

Exchange Rate Effect	11	-6	-79	-18	N/A
Beginning Cash Position	4,780	6,806	7,560	45	219
End Cash Position	4,670	4,780	6,806	7,560	45
Net Cash Flow	$-111	$-2,026	$-754	$7,515	$-175

Free Cash Flow
Operating Cash Flow	-25,235	-13,316	-10,268	-2,540	-372
Capital Expenditure	-18	N/A	-12	N/A	N/A
Free Cash Flow	-25,253	-13,316	-10,280	-2,540	-372